Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qingjie Jie Re granule plus oseltamivir in children with influenza
ChiCTR2200057418Phase 4Not yet recruiting
- Sponsor
- Children's Hospital of Fudan University
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Qingre Jiedu Decoction and oseltamivir in influenza (2 arms), sponsored by Children's Hospital of Fudan University. Primary endpoints: Time for complete fever reduction, Curative effect of TCM syndromes (cure rate) and 9 more. Planned start Dec 2021; status: not yet recruiting.
02
Drugs
Qingre Jiedu Decoctionoseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2200057418.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057418.